Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions, such as Alzheimer’s disease and traumatic brain injury, at low cost-;and do so accurately regardless of their skin tone.
FDA Plans to Ban Popular Cold Med
The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) nasal decongestion drugs after a comprehensive
November 8, 2024